Risk Factors for Ovarian Cancer in South America: A Literature Review.

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Journal of Personalized Medicine Pub Date : 2024-09-18 DOI:10.3390/jpm14090992
Sergio Jara-Rosales, Roxana González-Stegmaier, Elena S Rotarou, Franz Villarroel-Espíndola
{"title":"Risk Factors for Ovarian Cancer in South America: A Literature Review.","authors":"Sergio Jara-Rosales, Roxana González-Stegmaier, Elena S Rotarou, Franz Villarroel-Espíndola","doi":"10.3390/jpm14090992","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b> In 2020, ovarian cancer ranked fourth in global incidence among gynecological cancers and remains the deadliest cancer affecting women's health. Survival rates are significantly higher when the disease is detected at early stages; however, the lack of effective early detection methods underscores the importance of identifying risk factors in order to implement preventive strategies. The objective of this work is to provide an overview of the risk factors of ovarian cancer in South America, emphasizing those linked to social determinants, genetic components, and comorbidities. <b>Methods:</b> A literature search was performed using PubMed and Google Scholar. MeSH descriptors and keywords, such as \"<i>BRCA1</i> genes,\" \"<i>BRCA2</i> genes\", \"Latin America\", and \"ovarian neoplasms\" were used, along with terms related to socioeconomic and health factors. Inclusion criteria focused on original studies published in the last five years involving South American women. <b>Results:</b> Studies were identified from Argentina, Brazil, Chile, Colombia, Ecuador, and Peru. These studies addressed genetic factors, health status at diagnosis, and sociodemographic factors, revealing important data gaps, particularly on contraception and hormone replacement therapy. The prevalence of <i>BRCA1</i> and <i>BRCA2</i> mutations in South America is estimated to be 15-20% among women with inherited risk factors. Social, demographic and economic factors vary by country, although commonalities include a higher prevalence among women over 50 years of age, those with limited education, and those who face barriers to accessing health care. <b>Conclusions:</b> Although the literature does not conclusively establish a direct link between obesity and/or diabetes and the development of ovarian cancer, the indirect association highlights the need for further clinical studies. A general research gap related to risk factors of ovarian cancer could be observed in the South American region.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433525/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm14090992","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: In 2020, ovarian cancer ranked fourth in global incidence among gynecological cancers and remains the deadliest cancer affecting women's health. Survival rates are significantly higher when the disease is detected at early stages; however, the lack of effective early detection methods underscores the importance of identifying risk factors in order to implement preventive strategies. The objective of this work is to provide an overview of the risk factors of ovarian cancer in South America, emphasizing those linked to social determinants, genetic components, and comorbidities. Methods: A literature search was performed using PubMed and Google Scholar. MeSH descriptors and keywords, such as "BRCA1 genes," "BRCA2 genes", "Latin America", and "ovarian neoplasms" were used, along with terms related to socioeconomic and health factors. Inclusion criteria focused on original studies published in the last five years involving South American women. Results: Studies were identified from Argentina, Brazil, Chile, Colombia, Ecuador, and Peru. These studies addressed genetic factors, health status at diagnosis, and sociodemographic factors, revealing important data gaps, particularly on contraception and hormone replacement therapy. The prevalence of BRCA1 and BRCA2 mutations in South America is estimated to be 15-20% among women with inherited risk factors. Social, demographic and economic factors vary by country, although commonalities include a higher prevalence among women over 50 years of age, those with limited education, and those who face barriers to accessing health care. Conclusions: Although the literature does not conclusively establish a direct link between obesity and/or diabetes and the development of ovarian cancer, the indirect association highlights the need for further clinical studies. A general research gap related to risk factors of ovarian cancer could be observed in the South American region.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
南美洲卵巢癌的风险因素:文献综述。
背景/目标:2020 年,卵巢癌在全球妇科癌症发病率中排名第四,仍然是影响妇女健康的最致命癌症。如果能在早期发现该疾病,存活率会大大提高;然而,由于缺乏有效的早期检测方法,这就凸显了识别风险因素以实施预防策略的重要性。这项工作的目的是概述南美洲卵巢癌的风险因素,强调与社会决定因素、遗传因素和合并症有关的风险因素。研究方法使用 PubMed 和 Google Scholar 进行文献检索。使用了 MeSH 描述词和关键词,如 "BRCA1 基因"、"BRCA2 基因"、"拉丁美洲 "和 "卵巢肿瘤",以及与社会经济和健康因素相关的术语。纳入标准侧重于过去五年中发表的涉及南美女性的原创研究。结果:确定了来自阿根廷、巴西、智利、哥伦比亚、厄瓜多尔和秘鲁的研究。这些研究涉及遗传因素、诊断时的健康状况和社会人口因素,揭示了重要的数据缺口,尤其是关于避孕和激素替代疗法的数据。据估计,在南美洲具有遗传风险因素的妇女中,BRCA1 和 BRCA2 基因突变的发病率为 15-20%。各国的社会、人口和经济因素各不相同,但共同点包括 50 岁以上女性、受教育程度有限的女性以及在获得医疗保健服务方面面临障碍的女性患病率较高。结论:虽然文献并未最终确定肥胖和/或糖尿病与卵巢癌的发生有直接联系,但这种间接联系强调了进一步临床研究的必要性。在南美地区,有关卵巢癌风险因素的研究普遍存在空白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
期刊最新文献
Applications of Artificial Intelligence-Based Systems in the Management of Esophageal Varices. Clinical and Laboratory Parameters Associated with PICU Admission in Children with Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C). Oral Care in Head and Neck Radiotherapy: Proposal for an Oral Hygiene Protocol. Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study. Melatonin Receptors and Serotonin: Age-Related Changes in the Ovaries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1